Safety and immunogenicity of the nonavalent human papillomavirus (nHPV) vaccine in Spanish Women Living with HIV (WLHIV)

被引:0
|
作者
Hidalgo-Tenorio, C. [1 ]
Gomez-Ronquillo, P. [2 ]
Moya, R. [2 ]
Pasquau, J. [1 ]
Omar Mohamed, M. [3 ]
Sam Pedro, A. [4 ]
Vinuesa, D. [5 ]
Lopez-Hidalgo, J. [6 ]
Lopez Ruz, M. A. [1 ]
Sequera-Arquelladas, S. [1 ]
Garcia-Vallecillos, C. [1 ]
机构
[1] Univ Hosp Virgen de las Nieves, Infect Dis Unit, Granada, Spain
[2] Univ Hosp Virgen de las Nieves, Internal Med Serv, Granada, Spain
[3] Complejo Hosp Jaen, Infect Dis Unit, Jaen, Spain
[4] Univ Hosp San Cecilio, Microbiol Serv, Granada, Spain
[5] Univ Hosp San Cecilio, Infect Dis Unit, Granada, Spain
[6] Univ Hosp Virgen de las Nieves, Pathol Serv, Granada, Spain
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
PE6/8
引用
收藏
页码:260 / 260
页数:1
相关论文
共 50 条
  • [31] Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Indian women
    Bhatla, Neerja
    Suri, Vanita
    Basu, Partha
    Shastri, Surendra
    Datta, Sanjoy K.
    Bi, Dan
    Descamps, Dominique J.
    Bock, Hans L.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2010, 36 (01) : 123 - 132
  • [32] Keratinocyte Carcinomas in Immunocompromised Patients Are Reduced After Administration of the Nonavalent Human Papillomavirus Vaccine
    Nichols, Anna J.
    Nahm, William J.
    Rabinovitz, Harold
    Ioannides, Tim
    JOURNAL OF DRUGS IN DERMATOLOGY, 2022, 21 (05) : 526 - 528
  • [33] Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKD
    Nelson, Delphine R.
    Neu, Alicia M.
    Abraham, Alison
    Amaral, Sandra
    Batisky, Donald
    Fadrowski, Jeffrey J.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (05): : 776 - 784
  • [34] Immunogenicity of Human Papillomavirus Recombinant Vaccine in Children with CKD
    Nelson, D.
    Neu, A.
    Abraham, A.
    Amaral, S.
    Batisky, D.
    Fadrowski, J.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1747 - 1748
  • [35] The Efficacy of the Quadrivalent Human Papillomavirus Vaccine in Girls and Women Living With Human Immunodeficiency Virus
    McClymont, Elisabeth
    Lee, Marette
    Raboud, Janet
    Coutlee, Francois
    Walmsley, Sharon
    Lipsky, Nancy
    Loutfy, Mona
    Trottier, Sylvie
    Smaill, Fiona
    Klein, Marina B.
    Harris, Marianne
    Cohen, Jeffrey
    Yudin, Mark H.
    Wobeser, Wendy
    Money, Deborah
    Alimenti, Ariane
    Azampanah, Arezou
    Bitnun, Ari
    Blitz, Sandra
    Brophy, Jason
    Christilaw, Jan
    Coldman, Andrew
    Dobson, Simon
    Hankins, Catherine
    Karatzios, Christos
    Krajden, Mel
    Lapointe, Normand
    McAlpine, Jessica
    Miller, Dianne
    Moses, Erin
    van Niekerk, Dirk
    Ogilvie, Gina
    Pick, Neora
    Samson, Lindy
    van Schalkwyk, Julie
    Scheifele, David
    Singer, Joel
    Stone, Sarah
    Stuart, Gavin
    Summers, Marcie
    Vicol, Laura
    Watt, Melissa
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (05) : 788 - 794
  • [36] Clearance of genital warts in a pediatric patient following administration of the nonavalent human papillomavirus vaccine
    Couselo-Rodriguez, Carmen
    Perez-Feal, Patricia
    Alarcon-Perez, Camilo E.
    Bou-Boluda, Laia
    Baselga, Eulalia
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2021, 60 (09) : E377 - E379
  • [37] Immunogenicity and safety of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccine versus two doses of nonavalent vaccine - A randomized clinical trial
    Gilca, Vladimir
    Sauvageau, Chantal
    Panicker, Gitika
    De Serres, Gaston
    Ouakki, Manale
    Unger, Elizabeth R.
    VACCINE, 2018, 36 (46) : 7017 - 7024
  • [38] Clinical trial demonstrates immunogenicity and safety of HPV vaccine in HIV-positive women
    Wilkinson, Jonathan
    FUTURE MICROBIOLOGY, 2014, 9 (06) : 721 - 722
  • [39] Clinical trial demonstrates immunogenicity and safety of HPV vaccine in HIV-positive women
    Wilkinson, Jonathan
    FUTURE VIROLOGY, 2014, 9 (06) : 546 - 547
  • [40] Prospective longitudinal study on immunogenicity and safety of vaccination against human papillomavirus (HPV) with the 9valent vaccine in HIV-positive women, the Papillon study: preliminary results on tolerance and safety
    Konopnicki, D.
    Gilles, C.
    Manigart, Y.
    Barlow, P.
    Reschner, A.
    Necsoi, C.
    Delforge, M.
    De Wit, S.
    HIV MEDICINE, 2019, 20 : 178 - 178